278 related articles for article (PubMed ID: 34015206)
1. The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment.
Kim SH; Lim YJ
Intest Res; 2022 Jan; 20(1):31-42. PubMed ID: 34015206
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and clinical relevance of probiotics and synbiotics in colorectal carcinogenesis: a systematic review.
Cruz BCS; Sarandy MM; Messias AC; Gonçalves RV; Ferreira CLLF; Peluzio MCG
Nutr Rev; 2020 Aug; 78(8):667-687. PubMed ID: 31917829
[TBL] [Abstract][Full Text] [Related]
4. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model.
Dos Santos Cruz BC; da Silva Duarte V; Giacomini A; Corich V; de Paula SO; da Silva Fialho L; Guimarães VM; de Luces Fortes Ferreira CL; Gouveia Peluzio MDC
Appl Microbiol Biotechnol; 2020 Oct; 104(20):8837-8857. PubMed ID: 32902682
[TBL] [Abstract][Full Text] [Related]
5. Probiotics, prebiotics and colorectal cancer prevention.
Ambalam P; Raman M; Purama RK; Doble M
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
[TBL] [Abstract][Full Text] [Related]
6. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
7. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer.
Raman M; Ambalam P; Kondepudi KK; Pithva S; Kothari C; Patel AT; Purama RK; Dave JM; Vyas BR
Gut Microbes; 2013; 4(3):181-92. PubMed ID: 23511582
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients.
Shimizu K; Ojima M; Ogura H
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371948
[TBL] [Abstract][Full Text] [Related]
9. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
[TBL] [Abstract][Full Text] [Related]
10. The interplay between dietary factors, gut microbiome and colorectal cancer: a new era of colorectal cancer prevention.
Seesaha PK; Chen X; Wu X; Xu H; Li C; Jheengut Y; Zhao F; Liu L; Zhang D
Future Oncol; 2020 Mar; 16(7):293-306. PubMed ID: 32067473
[TBL] [Abstract][Full Text] [Related]
11. Probiotics, prebiotics, synbiotics and insulin sensitivity.
Kim YA; Keogh JB; Clifton PM
Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
[TBL] [Abstract][Full Text] [Related]
12. Microbial Interactions and Interventions in Colorectal Cancer.
Van Raay T; Allen-Vercoe E
Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
[TBL] [Abstract][Full Text] [Related]
13. The gut microbiome modulates colon tumorigenesis.
Zackular JP; Baxter NT; Iverson KD; Sadler WD; Petrosino JF; Chen GY; Schloss PD
mBio; 2013 Nov; 4(6):e00692-13. PubMed ID: 24194538
[TBL] [Abstract][Full Text] [Related]
14. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?
Geier MS; Butler RN; Howarth GS
Cancer Biol Ther; 2006 Oct; 5(10):1265-9. PubMed ID: 16969130
[TBL] [Abstract][Full Text] [Related]
15. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics.
Satokari R
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443276
[TBL] [Abstract][Full Text] [Related]
17. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
19. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
Simon E; Călinoiu LF; Mitrea L; Vodnar DC
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review.
Martín-Peláez S; Cano-Ibáñez N; Pinto-Gallardo M; Amezcua-Prieto C
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
